Batoclimab (Anti-FcRn (FCGRT & B2M))

Synonyms: HBM9161; IMVT-1401

Batoclimab (anti-FcRn (FCGRT & B2M)) is a human monoclonal antibody directed against the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. It has the potential to be used in research on autoimmune diseases mediated by pathogenic IgG antibodies. MW: 143.76 kD.

Batoclimab (Anti-FcRn (FCGRT & B2M))

Purity & Quality Control

≥99

Biological Activity

Description Batoclimab (anti-FcRn (FCGRT & B2M)) is a human monoclonal antibody directed against the neonatal crystallizable fragment receptor (FcRn) with potential immunomodulating activity. It has the potential to be used in research on autoimmune diseases mediated by pathogenic IgG antibodies. MW: 143.76 kD.

Product Details

CAS No. 2187430-05-1
Molecular Weight 143.76
Isotype Human IgG1
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac,pH5.0
Storage
(From the date of receipt)
Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Batoclimab (Anti-FcRn (FCGRT & B2M)) | Batoclimab (Anti-FcRn (FCGRT & B2M)) supplier | purchase Batoclimab (Anti-FcRn (FCGRT & B2M)) | Batoclimab (Anti-FcRn (FCGRT & B2M)) cost | Batoclimab (Anti-FcRn (FCGRT & B2M)) manufacturer | order Batoclimab (Anti-FcRn (FCGRT & B2M)) | Batoclimab (Anti-FcRn (FCGRT & B2M)) distributor